Olspas-P Oral Suspension
Images are for reference. Actual packaging may vary.
Mefenamic Acid (50mg/5ml) + Paracetamol (125mg/5ml)
Bottle of 60 ml • Syrup
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Olspas-P Oral Suspension is a combination analgesic and antipyretic formulation containing Mefenamic Acid (50mg/5ml) and Paracetamol (125mg/5ml). Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol, an analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever, though its exact mechanism remains partially understood.
This synergistic combination is indicated for the relief of mild to moderate pain associated with conditions such as musculoskeletal disorders, dental pain, dysmenorrhea, and febrile states. Olspas-P Oral Suspension offers a convenient liquid formulation suitable for pediatric and adult patients who have difficulty swallowing tablets. The recommended dosage should be adhered to strictly to minimize the risk of adverse effects.
Common side effects may include gastrointestinal discomfort, nausea, and allergic reactions, while prolonged use or overdose may lead to hepatotoxicity or renal impairment. Caution is advised in patients with pre-existing liver or kidney disease, peptic ulcer, or hypersensitivity to NSAIDs or paracetamol. Consultation with a healthcare professional is essential prior to use, especially in children, pregnant or lactating women, and those on concurrent medications.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olspas-P Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment of Olspas-P Oral Suspension may be needed. Please consult your doctor. Use of Olspas-P Oral Suspension is not recommended in children with severe kidney disease.
Exercise Caution
Olspas-P Oral Suspension should be used with caution in patients with liver disease. Dose adjustment of Olspas-P Oral Suspension may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Olspas-P Oral Suspension






